Wendong Li

The First Affiliated Hospital of Zhengzhou University

H指数:33

被引数:4,086

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Three Dimensional Printing Assisted Multifenestrated Endovascular Repair of the Aortic Arch: A Multicentre Study

三维打印辅助的多孔道腔内修复术治疗主动脉弓病变：一项多中心研究

European Journal of Vascular and Endovascular Surgery

IF6.8

2025-12-090

PRE

Ubiquitination of Rhbdf2 by Cop1 alleviates Hepatic ischemia-reperfusion injury by regulating the TAK1– JNK/p38 signaling pathway

Cop1介导的Rhbdf2泛素化通过调控TAK1–JNK/p38信号通路减轻肝缺血再灌注损伤

Cellular and Molecular Gastroenterology and Hepatology

IF7.4

2025-12-050

OAAI

RNA m5C methylation in cancer: mechanisms and biological impact

癌症中的RNA m5C甲基化：机制与生物学影响

Oncogenesis

IF6.4

2025-11-210

OAAI

Evaluating the Immunological Properties of Recombinant Hepatitis B Surface Antigen Using a Multitiered In Vivo and In Vitro Approach

评估重组乙型肝炎表面抗原的免疫学特性：采用多层级体内和体外方法

Viral Immunology

IF1.2

2025-10-010

PRE

Development and Performance Analysis of Boundary-Reinforced Carbon Fiber-Based Buoyancy Structures

边界增强型碳纤维基浮力结构的设计与性能分析

Thin-Walled Structures

IF6.6

2025-09-110

PRE

Slowly digestible starch content of corn flour increased by protein after annealing treatment thereby reducing diabetic damage

慢消化淀粉含量在经过热处理后的玉米粉中因蛋白质而增加，从而减少糖尿病损伤

International Journal of Biological Macromolecules

IF8.5

2025-08-040

PRE

Patients with uHCC and Child-Pugh B8/9 also benefit from a combination of antiangiogenic agents and PD-1 inhibitors: a multicenter real-world study

uHCC和Child-Pugh B8/9分级的患者从抗血管生成剂与PD-1抑制剂的联合治疗中获益：一项多中心真实世界研究

ACTA ONCOLOGICA

IF2.2

2025-05-050

Development and Validation of a Diagnostic Model for Stanford Type B Aortic Dissection Based on Proteomic Profiling

基于蛋白质组学的Stanford b型主动脉夹层诊断模型的建立与验证

inflammation research

IF4.1

2025-01-010

Prognostic value of the neutrophil-to-lymphocyte ratio and prognostic nutritional index in unresectable hepatocellular carcinoma patients treated with tyrosine kinase inhibitors and immune checkpoint inhibitors

HUMAN VACCINES & IMMUNOTHERAPEUTICS

IF3.5

2024-12-120

OAAI

Buckling analysis of moderately thick carbon fiber composite cylindrical shells under hydrostatic pressure

APPLIED OCEAN RESEARCH

IF4.4

2024-12-0128

PRE

The clinical significance of sarcopenia in patients with hepatocellular carcinoma treated with lenvatinib and PD-1 inhibitors

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-04-183

OAAI

Rare, Tightly-Bound, Multi-Cellular Clusters in the Pancreatic Ducts of Adult Mice Function Like Progenitor Cells and Survive and Proliferate After Acinar Cell Injury

Stem Cells

IF3.6

2024-01-112

OAAI

Non-coding RNAs regulating endothelial progenitor cells for venous thrombosis: promising therapy and innovation

STEM CELL RESEARCH & THERAPY

IF7.3

2024-01-021

OAAI

Inhibition of USP7 upregulates USP22 and activates its downstream cancer-related signaling pathways in human cancer cells

CELL COMMUNICATION AND SIGNALING

IF8.9

2023-11-095

OAAI

TRPM8 as a Potential Biomarker and Therapeutic Target for Gastric Cancer Identified by a Combination of Text Mining and RNA Sequencing

CURRENT GENE THERAPY

IF3.3

2023-10-013

PRE

Effect of protein on the gelatinization behavior and digestibility of corn flour with different amylose contents

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

IF8.5

2023-09-018

PRE

A Newly Identified Spike Protein Targeted Linear B-Cell Epitope Based Dissolvable Microneedle Array Successfully Eliciting Neutralizing Activities against SARS-CoV-2 Wild-Type Strain in Mice

ADVANCED SCIENCE

IF14.1

2023-05-104

OAAI

Impaired Humoral Immunity Identified in Inactivated SARS-CoV-2 Vaccine Recipients without Anti-Spike RBD Antibodies

MICROBIOLOGY SPECTRUM

IF3.8

2023-04-130

OAAI

Role of intra- tumoral bacteria in EGFR-tyrosine kinase inhibitor resistance

CANCER RESEARCH

IF16.6

2023-04-041

PRE

Inhibition of USP7 upregulates USP22 through desuppression of transcriptional activity of Sp1 in human cancer cells

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Wendong Li

个人简介

教育背景

工作经历

荣誉奖项

研究方向